Capital Markets and Public M&A

We give qualified advice on company law and legal matters regarding capital markets to listed companies, their owners and other stakeholders acting on the Swedish stock market.

As a leading team in this area, we have in depth knowledge of the regulatory system for stock market transactions, and can add value in both strategic and structural matters.

The team is heavily involved in developing the regulations in this area, and we have well established contacts with authorities and other participants on the Swedish stock market.

Through our international network, we regularly handle transactions that span two or more jurisdictions.

Our consultancy

The team has specialist competence in Equity Capital Market transactions (such as listings, capital raising and sell downs), as well as public M&A.

Vinge also has extensive experience advising on: disclosure matters (rules on disclosure of information, market abuse and disclosure of shareholding and short selling); corporate governance (preparing for general meetings, questions about board composition and reporting); and incentive programmes for listed companies.

Because no two transactions are the same, we put together a unique team for each project – one that is built around the client’s needs.

Our collective expertise

Clients will find they work with a team that has detailed knowledge of business law and is readily available to them.  Because we are a full‑service firm, we can support our clients in all their business law matters.

What the ranking organisations say

One impressed client enthuses: They have delivered over and above what could be expected, demonstrating an extremely high level of client service, availability and know-how.

Another client praises the team's "attentiveness and sense of urgency" as well as its "ability to draw fast and correct conclusions and focus on the important matters." (Chambers and Partners 2020)

Latest news and mandates

Vinge advised Trianon on directed share issue

Vinge advised Fastighets AB Trianon in connection with a directed share issue of SEK 115 million through an accelerated book building procedure.

July 10, 2020

Vinge has advised Vicore Pharma in connection with a directed share issue of approximately SEK 185 million

Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 185 million in issue proceeds.

July 08, 2020

Vinge advised IVISYS on directed share issue

Vinge advised IVISYS AB in connection with a directed share issue through an accelerated book building procedure.

July 07, 2020